Related references
Note: Only part of the references are listed.Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein
Jens Kuhle et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab
L Steinman
NATURE REVIEWS DRUG DISCOVERY (2005)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Monoclonal antibodies selective for low molecular weight neurofilaments
N Norgren et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Share Paper
